Drugmakers go nuclear, continuing push into radiopharmaceuticals
Drugmakers go nuclear, continuing push into radiopharmaceuticals
About this item
Full title
Drugmakers go nuclear, continuing push into radiopharmaceuticals
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Nature biotechnology, 2021-06, Vol.39 (6), p.647-649
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
With late-stage trial success, venture funding and next-generation alpha emitters on the way, targeted radiotherapy drugs are finally “getting the attention they deserve.”
Alternative Titles
Full title
Drugmakers go nuclear, continuing push into radiopharmaceuticals
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2540514614
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2540514614
Other Identifiers
ISSN
1087-0156
E-ISSN
1546-1696
DOI
10.1038/s41587-021-00954-z
How to access this item
Log in as a Library member
